Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

View source ↗

Summary

This clinical trial update describes a screening protocol from NIAID to identify genetic diseases of lymphocyte homeostasis and programmed cell death in individ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Primary Immune Deficiency | Status: RECRUITING